WikiCitingRetracted

A phase II, double-blind, placebo-controlled, ascending-dose study of Eritoran (E5564), a lipid A antagonist, in patients undergoing cardiac surgery withae

Target ArticleEdit

A phase II, double-blind, placebo-controlled, ascending-dose study of Eritoran (E5564), a lipid A antagonist, in patients undergoing cardiac surgery withae; E Bennett; 2007; doi_citing_unknown

RetractionEdit

Endotoxaemia during left ventricular assist device insertion: relationship between risk factors and outcome  ; Catherine M N O'Malley Robert J Frumento B Mets Y Naka; 01/01/2004

https://doi.org/10.1093/bja/aeh010

Citation pieceEdit

Note: Open to append information.

Retrieved from "https://wikicitingretracted.org/index.php?title=A_phase_II,_double-blind,_placebo-controlled,_ascending-dose_study_of_Eritoran_(E5564),_a_lipid_A_antagonist,_in_patients_undergoing_cardiac_surgery_withae&oldid=7325"